NYSEARCA:PJP Invesco Pharmaceuticals ETF (PJP) Price, Holdings, & News $120.88 -0.36 (-0.30%) Closing price 04:10 PM EasternExtended Trading$120.88 +0.01 (+0.00%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsNews and TrendsOwnershipRatingsShort Interest About Invesco Pharmaceuticals ETF (NYSEARCA:PJP) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get PJP alerts:Sign Up Key Stats Today's Range$120.55▼$121.6650-Day Range$120.37▼$131.6452-Week Range$92.10▼$131.68Volume21,600 shsAverage Volume36,194 shsMarket Capitalization$542.75 millionAssets Under Management$545.90 millionDividend Yield0.93%Net Expense Ratio0.57%Aggregate RatingModerate Buy ETF Overview PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The Fund normally invests at least 90% of its total assets in common stocks that consists of the Index. The Fund's investment advisor is Invesco PowerShares Capital Management LLC. Read More Invesco Pharmaceuticals ETF ExpensesTypePJPHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.50%0.55%0.57%0.50%0.53%Other Expenses0.07%0.52%0.53%0.60%0.54%Total Expense0.57%0.76%0.75%0.75%0.73%Fee Waiver0.00%-0.85%-0.67%-0.78%-0.68%Net Expense0.57%0.58%0.63%0.57%0.60% Receive PJP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Invesco Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PJP ETF News HeadlinesXLV vs. PJP: How Broad Healthcare Diversification Stacks Up to Pharma StocksSeptember 23, 2026 | finance.yahoo.comInvesco Pharmaceuticals vs iShares Healthcare: Which Healthcare ETF Brings Better ProfitsSeptember 8, 2026 | finance.yahoo.comMILLIONAIRE MASTERCLASS INVITE: AltucherJames Altucher says Elon Musk is preparing an unprecedented project set to surface on December 8th. Altucher is hosting a free masterclass revealing what he says is locked inside a sealed briefcase detailing Musk's plans. Attendees who join early can also access a $1,000 bonus offer included with the presentation.October 2 at 1:00 AM | Paradigm Press (Ad)FHLC vs. PJP: Which Healthcare ETF Is the Better Buy for Investors?August 23, 2026 | fool.comThese New Drugs Could Fuel Fresh Highs for Biotech and Pharma StocksAugust 7, 2026 | barrons.comInvesco Pharmaceuticals ETFJuly 31, 2026 | money.usnews.comSee More Headlines PJP ETF - Frequently Asked Questions How have PJP shares performed this year? Invesco Pharmaceuticals ETF's stock was trading at $104.54 at the beginning of 2026. Since then, PJP stock has increased by 15.6% and is now trading at $120.88. How do I buy shares of Invesco Pharmaceuticals ETF? Shares of PJP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Invesco Pharmaceuticals ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Invesco Pharmaceuticals ETF investors own include NVIDIA (NVDA), Meta Platforms (META), Walt Disney (DIS), Affirm (AFRM), Advanced Micro Devices (AMD), Netflix (NFLX) and Pfizer (PFE). Fund Details IssuerInvesco Fund NameInvesco Pharmaceuticals ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:PJP Inception Date6/23/2005 Fund ManagerPeter Hubbard, Michael Jeanette, Pratik Doshi, Tony Seisser Webwww.invescopowershares.com Phone+1-800-9830903Fund Focus Asset ClassEquity BenchmarkDynamic Pharmaceutical Intellidex Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings29 Fund Statistics Assets Under Management$545.90 million Average Daily Volume$43.51 thousand Discount/Premium-0.07% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorInvesco Capital Management, LLC CustodianThe Bank of New York Mellon Corporation DistributorInvesco Distributors, Inc. Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerCitadel Options OptionableN/A Short Interest7,633 shs Miscellaneous Outstanding Shares4,490,000Beta0.44 Creation Unit10,000 Creation Fee$500.00 The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report Top 10 PJP HoldingsGilead Sciences (NASDAQ:GILD)Holding Weight: 5.59%AbbVie (NYSE:ABBV)Holding Weight: 5.47%Johnson & Johnson (NYSE:JNJ)Holding Weight: 5.45%Pfizer (NYSE:PFE)Holding Weight: 5.33%Merck & Co., Inc. (NYSE:MRK)Holding Weight: 5.18%Eli Lilly and Company (NYSE:LLY)Holding Weight: 5.15%Abbott Laboratories (NYSE:ABT)Holding Weight: 4.85%Amgen (NASDAQ:AMGN)Holding Weight: 4.73%Tarsus Pharmaceuticals (NASDAQ:TARS)Holding Weight: 3.48%Harmony Biosciences (NASDAQ:HRMY)Holding Weight: 3.46%Full Holdings DetailsPJP Sector ExposurePJP Industry Exposure This page (NYSEARCA:PJP) was last updated on 10/2/2026 by MarketBeat.com Staff. From Our PartnersElon Warns "America Will Go Bankrupt". Trump's Plan Inside.National debt just crossed 40 trillion dollars, and Elon Musk says America is 1,000% going to go bankrupt with...American Hartford Gold | SponsoredHow options let you do more with less capitalWould you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fractio...Base Camp Trading | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredWATCH THIS BEFORE DECEMBER 8th!!James Altucher says a quiet government filing could reveal Elon Musk's biggest move yet, and almost nobody has...Paradigm Press | SponsoredHow Elon’s Empire Ends (and how to profit)Marc Chaikin, the 60 year Wall Street veteran whose Chaikin Money Flow indicator sits on every Bloomberg termi...Chaikin Analytics | SponsoredMajor Buy Alert Issued for October 31stKeith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...TradeSmith | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Pharmaceuticals ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
